Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

ASSEMBLY BIOSCIENCES, INC. Director's Dealing 2024

Oct 4, 2024

33081_dirs_2024-10-04_43881d11-741a-43bf-8ff8-ebef536c2c78.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: ASSEMBLY BIOSCIENCES, INC. (ASMB)
CIK: 0001426800
Period of Report: 2024-10-03

Reporting Person: White Nicole S (N/A)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2024-10-03 Common Stock S 157 $14.81 Disposed 11911 Direct

Footnotes

F1: The sale reported on this Form 4 represents shares sold by the reporting person to cover tax withholding obligations in connection with the vesting and settlement of restricted stock units. The sale is mandated by an administrative rule adopted by the Compensation Committee of the Issuer's Board of Directors that requires the satisfaction of tax withholding obligations to be funded by a "sell-to-cover" transaction and does not represent a discretionary transaction by the reporting person.